Author:
Jain Akhil, ,Desai Rupak, ,Devaragudi Sanjana, ,Kaur Loveneet, ,Singh Kulwinder, ,Bawa Jerrin, ,Theik Nyein Wint Yee, ,Palisetti Spandana,
Publisher
S.C. JURNALUL PENTRU MEDICINA SI VIATA S.R.L
Reference11 articles.
1. The worldwide incidence and prevalence of systemic lupus erythematosus: a systematic review of epidemiological studies;Rees F, Doherty M, Grainge MJ, Lanyon P, Zhang W;Rheumatology,2017
2. A review on SLE and malignancy;Choi MY, Flood K, Bernatsky S, Ramsey-Goldman R, Clarke AE;Best Pract Res Clin Rheumatol,2017
3. Increased risk of malignancy in patients with systemic lupus erythematosus: population-based cohort study in Korea;Han JY, Kim H, Jung SY, Jang EJ, Cho SK, Sung YK;Arthritis Res Ther,2021
4. Systemic lupus erythematous and malignancy risk: a meta-analysis;Cao L, Tong H, Xu G, Scheurer M;PLoS ONE,2015
5. Successful treatment with autologous peripheral blood stem cell transplantation for multiple myeloma concurrent systemic lupus erythematosus: A case report;Ding L, Huang L, Xu Y, Xiao X, Yuan X, Tong J;Int J Clin Exp Med,2017